Wednesday, July 30, 2014 8:00:35 PM
Series B. 500,000 S/O
Each series B converts 1:500 = 250,000,000 of common shares.
Series C 19,738,646 S/O
Each series C converts 1:500=9,869,323,646 of common shares.
restricted 18 month from March 27th 2014
Series E 22,155,729 S/O
Each series E converts 1:500 = 11,077,864,500 of common shares.
restricted 12 month from March 27th 2014
---------------------------------------------------
Total Series B,C,E converted = 21,197,188,146 common shares
Current as of July 23rd 2014
Authorized Shares = 20bil
Outstanding Shares =5,394,024,814
Full disclosure; Im long this stock. All statements, posts, comments I make are of my opinion only unless noted with sources and or links to give creditability to being a fact.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM